I have never used it, so I can't be of much help, but I personally think that if you are taking it to do better in med school, don't do it! I looked it up in Micromedex for you. See below!
DrugPoint® Summary
AMPHETAMINE/DEXTROAMPHETAMINE
Details in DRUGDEX® DEXTROAMPHETAMINE
AMPHETAMINE
Tradenames Adderall
Adderall XR
See Complete Tradename Listing
Black Box Warning Amphetamines have a high potential for abuse. Administration of amphetamines for prolonged periods of time may lead to drug dependence and must be avoided. Particular attention should be paid to the possibility of subjects obtaining amphetamines for non-therapeutic use or distribution to others and the drugs should be prescribed or dispensed sparingly.
Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events .
Class Central Nervous System Agent
CNS Stimulant
Adult Dose Attention deficit hyperactivity disorder: extended-release, 20 mg ORALLY daily
Narcolepsy: immediate-release, 5-60 mg/day ORALLY in divided doses
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Pediatric Dose not FDA approved in children under 3 years of age
Attention deficit hyperactivity disorder: (6-12 yr ) extended release, initial 10 mg ORALLY every morning (alternatively, 5 mg/day if appropriate); may increase daily dose in 5-10 mg increments at weekly intervals until optimal response; MAX 30 mg/day
Attention deficit hyperactivity disorder: (13-17 yr) extended release, initial 10 mg ORALLY every morning; may increase to 20 mg/day after 1 week
Attention deficit hyperactivity disorder: (age 3-5 yr) immediate release, initial 2.5 mg ORALLY every morning; may increase daily dose in 2.5 mg increments at weekly intervals until optimal response
Attention deficit hyperactivity disorder: (age 6 yr and older) immediate release, initial 5 mg ORALLY once or twice daily; may increase daily dose in 5 mg increments at weekly intervals until optimal response; MAX 40 mg/day
Narcolepsy: (age 6-12 yr) immediate release, 5 mg ORALLY once daily; may increase daily dose in 5 mg increments at weekly intervals until optimal response
Narcolepsy: (age 12 yr and older) immediate release, 10 mg ORALLY once daily; may increase daily dose in 10 mg increments at weekly intervals until optimal response
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Administration ORAL: avoid late evening doses due to resulting insomnia
ORAL: give first dose on awakening, additional doses at 4-6 hr intervals
ORAL: (extended-release) capsules may be swallowed whole or the entire capsule contents may be sprinkled on applesauce and consumed immediately; the applesauce with sprinkled beads should be consumed in its entirety without chewing
ORAL: (extended-release) do not divide the dose of a single capsule; patients should not take anything less than one capsule per day
ORAL: (extended-release) may be taken with or without food
Monitoring ADHD, narcolepsy: symptomatic improvement
blood pressure,pulse
pediatric patients: development and growth
How Supplied Oral Capsule, Extended Release: (Amphetamine Aspartate - Amphetamine Sulfate - Dextroamphetamine Saccharate - Dextroamphetamine Sulfate) 5 MG, 10 MG, 15 MG, 20 MG, 25 MG, 30 MG
Oral Tablet: (Amphetamine Aspartate - Amphetamine Sulfate - Dextroamphetamine Saccharate - Dextroamphetamine Sulfate) 5 MG, 7.5 MG, 10 MG, 12.5 MG, 15 MG, 20 MG, 30 MG
Indications FDA labeled indications
Attention deficit hyperactivity disorder
Narcolepsy
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Contraindications advance arteriosclerosis, symptomatic cardiovascular disease
agitated states
glaucoma
history of drug abuse
hypersensitivity/idiosyncrasy to sympathomimetic amines
hyperthyroidism
MAOI therapy within 14 days
moderate to severe hypertension
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Precautions avoid abrupt discontinuation in patients with prolonged exposure
hypertension, mild to severe
long-term use may be associated with growth inhibition
may exacerbate motor and phonic tics and Tourette's syndrome
misuse of amphetamines may cause sudden death and serious cardiovascular events
pediatric cardiac abnormalities (including undiagnosed)
psychosis
structural cardiac abnormalities (including undiagnosed)
Adverse Effects COMMON
Endocrine metabolic: Weight loss
Gastrointestinal: Abdominal pain, Loss of appetite, Xerostomia
Neurologic: Headache, Insomnia, Tremor
Psychiatric: Dysphoric mood, Euphoria, Nervousness, Restlessness
SERIOUS
Cardiovascular: Cardiomyopathy (rare), Chest pain (rare), Hypertension, Irregular heart rate, Myocardial infarction (rare), Palpitations, Tachyarrhythmia, Unexplained sudden death, children, adolescents
Endocrine metabolic: Body temperature above normal (rare)
Immunologic: Allergic reaction (rare)
Neurologic: Central nervous system stimulation (Severe), Cerebrovascular accident (rare), Gilles de la Tourette's syndrome, Seizure (rare)
Psychiatric: Psychotic disorder, With prolonged use
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Drug Interaction Contraindicated
Clorgyline (established)
Furazolidone (theoretical)
Iproniazid (probable)
Isocarboxazid (established)
Moclobemide (probable)
Nialamide (probable)
Pargyline (probable)
Phenelzine (established)
Procarbazine (probable)
Selegiline (established)
Sibutramine (theoretical)
Toloxatone (probable)
Tranylcypromine (established)
Major
Chlorpromazine (theoretical)
Moderate
Guanethidine (probable)
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Pregnancy Category Amphetamine: C
Dextroamphetamine: C
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Breast Feeding Amphetamine: Infant risk has been demonstrated.
Dextroamphetamine: Infant risk has been demonstrated.
Details in DRUGDEX®
DEXTROAMPHETAMINE
AMPHETAMINE
Notes U.S. Schedule II controlled substance
may interfere with urinary steroid determinations
© 1974-2006 Thomson MICROMEDEX. All rights reserved.
--------------------------------------------------------------------------------